查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1371900

到 2030 年眼瞼手術市場預測：按類型、性別、服務提供者和地區分類的全球分析

Blepharoplasty Market Forecasts to 2030 - Global Analysis By Type (Upper Eyelid Blepharoplasty, Lower Eyelid Blepharoplasty and Combination Eyelid Surgery), Gender, Service Provider and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球眼瞼手術市場規模為 40.8 億美元，預計預測期內年複合成長率為 9.6%，到 ​​2030 年將達到 77.5 億美元。

稱為眼瞼手術的外科手術旨在改善眼瞼的外觀，特別是上眼瞼、下眼瞼或兩者。這種整容手術可以打造更年輕、更清爽的外觀，並經常用於解決與眼瞼老化相關的眾多問題。眼瞼手術經常用於解決老化症狀，例如眼睛周圍下垂、皮膚多餘、皺紋和浮腫。除了美容功效外，眼瞼手術還可以幫助解決實際問題，例如上眼瞼下垂引起的視力障礙。有些人進行眼瞼手術是為了改善臉部的整體外觀，使其看起來更年輕。

英國美容整形外科醫師協會進行的研究發現，在封鎖期間，虛擬手術諮詢的請求激增了 70%，為封鎖後的面對面治療做準備。

高齡化社會對手術的需求不斷增加

人口高齡化、可支配所得增加以及改善外表的願望都促進了這一成長。此外，這種治療方法在美國以外的地區也越來越受歡迎，包括中國、日本和韓國。由於眼瞼手術需求的增加，包括非侵入性手術和最尖端科技在內的新型治療方法的開發也促進了該行業的擴張。高齡化人口保持年輕外表的願望是眼瞼手術的主要市場驅動力，預計這一趨勢將持續下去，支持市場擴張。

成本高

在美國，眼瞼手術的典型費用各不相同，取決於手術範圍、外科醫生的能力和地點等因素。有些潛在患者可能會因為手術費用過高而猶豫是否接受手術，特別是如果他們沒有足夠的健康保險或可支配所得。此外，手術可能會產生感染、出血和疤痕等副作用，這會阻礙患者接受治療並阻礙市場成長。

使用新手術技術進行客製化

由於手術方法和技術的改進，眼瞼手術變得更安全、更有效。該手術因其微創技術、恢復快、效果好而越來越受歡迎。眼瞼手術整形手術可以根據每位患者的獨特要求和目標進行客製化。例如，外科醫師可以調整手術程序來治療特定病症，例如上眼瞼下垂、下眼瞼浮腫或問題的組合。此外，由於等離子技術和雷射輔助設備等技術的發展，市場正在擴大。這些裝置提供精確且受控的組織消融和收緊，對鄰近組織幾乎沒有傷害。

由於健康保險的覆蓋範圍而引起的安全擔憂

引人注目的眼瞼手術相關問題和不利事件可能會破壞公眾的信任並拒絕潛在的患者。安全問題可能會導致監督和法規的加強。對於某些患者來說，進行眼瞼手術整形手術可能會因保險範圍有限或不存在而受到阻礙。潛在的患者可能會因為手術的自付費用而望而卻步，尤其是對於那些預算緊張的患者。整容手術（尤其是眼瞼手術術）法律的變化可能會影響市場。收緊法規和許可要求可能會增加執業成本並減少從業人員數量。

COVID-19 的影響

COVID-19 的爆發擾亂了全球醫療保健產業的運作。眼瞼手術受到了 COVID-19大流行的顯著影響。世界上多個國家實施了嚴格的封閉和社會隔離政策，限制了獲得醫療服務的機會，並減少了選擇眼瞼手術的患者數量。

預測期內上眼瞼眼瞼手術領域預計將是最大的

上眼瞼眼瞼手術術預計會有良好的生長，因為它是一種旨在改善上眼瞼外觀的整容手術。這種手術經常用於治療由老齡化、遺傳和其他因素引起的各種美學問題。透過解決上眼瞼多餘的皮膚和皺紋、影響視力的上眼瞼上垂或下垂以及上眼瞼區域浮腫或凸起的脂肪沉積等問題，上眼瞼眼瞼手術可以幫助您看起來更年輕。使外觀煥然一新，正在推動眼瞼手術市場的成長。

醫院部門預計在預測期內年複合成長率最高

由於在醫院接受整容手術的患者數量不斷增加以及使用尖端醫療技術提供眼瞼手術的醫院數量不斷增加，預計醫院領域在預測期內將以最高的年複合成長率成長。醫院工作人員將提供術後治療和指導，包括疼痛管理、開放性傷口護理以及減少腫脹和瘀傷的建議。一旦患者病情穩定並清醒，他們通常就會出院。醫院工作人員和外科醫生通常會向患者提供詳細的術後說明，包括有關眼部護理、藥物和早期復健期間應避免的活動的資訊。

佔比最大的地區：

預計亞太地區在預測期內將佔據最大的市場佔有率。這是由於該地區製藥和醫療設備製造商的存在以及中國和印度等國家老年人口的增加，這些都是促進該地區市場成長的因素。此外，由於人們對微創手術的意願日益增加，眼瞼手術市場預計將在預測期內成長。雙眼皮手術是亞洲國家（尤其是韓國）最受歡迎的手術，推動了該地區的市場成長。

複合年複合成長率最高的地區：

由於該地區存在幾個重要的主要企業以及醫療設備技術的快速進步，預計北美在預測期內將呈現最高的年複合成長率。市場擴張的主要驅動力是越來越多的人接受眼瞼手術術治療，以使用創新和複雜的美容技術（包括雷射換膚和真皮填充劑）來改善眼睛的外觀。這就是我正在做的事情。例如，根據2021年國際美容整形外科外科學會報告，美國完成了53,253例眼瞼整形手術，而美國估計完成了149,668例眼瞼整形手術；促進了區域市場成長。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場公司的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利害關係人
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球眼瞼手術市場：依類型

  • 上眼瞼手術
  • 下眼瞼手術
  • 混合眼瞼手術

第6章 全球眼瞼手術市場：性別

  • 女士
  • 男性

第7章 全球眼瞼手術市場：依服務提供者分類

  • 醫院
  • 診所
  • 門診手術中心

第8章 全球眼瞼手術市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第9章 進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章 公司簡介

  • Abbvie Inc
  • Allergan
  • Alma Lasers
  • Cynosure
  • Erchonia Corporation
  • Galderma
  • Grand Aespio Inc.
  • Hologic
  • Johnson & Johnson
  • LightScalpel
  • London Bridge Plastic Surgery
  • Lumenis
  • MA Corporation
  • Medline industries, inc.
  • Medtronic plc
  • Merz Pharma
  • Sientra
  • Sisram Medical Ltd
  • Surgical Holdings Ltd.
  • Valeant Pharmaceuticals International
  • Zimmer Biomet
Product Code: SMRC23957

According to Stratistics MRC, the Global Blepharoplasty Market is accounted for $4.08 billion in 2023 and is expected to reach $7.75 billion by 2030 growing at a CAGR of 9.6% during the forecast period. A surgical technique called blepharoplasty aims to improve the appearance of the eyelids, specifically the upper, lower, or both. This cosmetic procedure can produce a more young and refreshed appearance and is frequently used to address numerous issues connected to the aging of the eyelids. In order to address aging symptoms such sagging or extra skin, wrinkles, and puffiness around the eyes, blepharoplasty is frequently performed. In addition to its cosmetic advantages, blepharoplasty can help with practical problems including visual impairment brought on by sagging upper eyelids. Some people get blepharoplasty to make their face look better overall and look more youthful.

According to a study conducted by the British Association of Aesthetic Plastic Surgeons, requests for virtual consultations for surgical procedures jumped by 70% during the lockdown in preparation for in-person treatment following the lockdown.

Market Dynamics:

Driver:

Increasing demand for the surgery among the aged population

The aging of the population, rising disposable money, and the desire to improve one's look are all contributing causes to the growth. Furthermore, the treatment is becoming more and more popular outside of the United States as well, including in China, Japan, and South Korea. The development of novel treatments, including non-invasive procedures and cutting-edge technologies, as a result of the increasing demand for blepharoplasty has also helped the industry expand. The aging population's desire to maintain a youthful appearance is a major market driver for blepharoplasty, and this trend is anticipated to persist in the years to come, supporting market expansion.

Restraint:

High cost

Depending on the degree of the procedure, as well as other elements including the surgeon's competence and location, the typical cost of blepharoplasty surgery in the United States varies. Some prospective patients are discouraged from having the surgery because of its exorbitant cost, especially those who lack sufficient health insurance or disposable income. Additionally, there is a chance that the surgery can have side effects like infection, bleeding, and scarring, which discourages patients from having the treatment done which hamper the growth of the market

Opportunity:

Customization utilizing new surgical methods

Blepharoplasty has become safer and more efficient thanks to improvements in surgical methods and technology. The operation is becoming more and more popular, in part because of minimally invasive techniques, quick recoveries, and better results. Procedures for blepharoplasty can be customized to each patient's unique requirements and objectives. In order to treat specific symptoms, such as upper eyelid sagging, lower eyelid puffiness, or a combination of problems, surgeons might tailor the procedure. Additionally, the market is expanding as a result of technological developments such plasma technology and laser-assisted devices, which offer precise and controlled tissue ablation and tightening with little harm to neighbouring tissues.

Threat:

Safety concerns with health insurance coverage

High-profile blepharoplasty-related problems or adverse events can damage public confidence and turn away potential patients. There may be more oversight and regulations as a result of safety concerns. For certain patients, access to blepharoplasty procedures may be hampered by limited or non-existent insurance coverage. Potential patients may be discouraged by the procedure's out-of-pocket cost, especially those who are on a limited budget. The market may be impacted by modifications to laws governing cosmetic surgery, especially blepharoplasty. Stricter rules or licensing requirements may raise the cost of practicing and reduce the availability of practitioners, which may have an impact on how accessible the treatment and the market.

COVID-19 Impact

The COVID-19 outbreak has hampered operations in the global healthcare industry. Blepharoplasty surgery has been significantly impacted by the COVID-19 pandemic. Strict lockdowns and social segregation policies have been put in place by several nations around the world, which have disrupted access to healthcare services and lowered the number of patients choosing to have blepharoplasty.

The upper eyelid blepharoplasty segment is expected to be the largest during the forecast period

The upper eyelid blepharoplasty segment is estimated to have a lucrative growth, as it is a type of cosmetic surgery that aims to improve the appearance of the upper eyelids. This surgery is frequently used to treat a variety of aesthetic issues brought on by aging, heredity, or other factors. By addressing concerns like extra skin and wrinkles on the top eyelids, hooded or drooping upper eyelids that may impair vision, and puffy or bulging fat deposits in the upper eyelid area, upper eyelid blepharoplasty aims to produce a more youthful and rejuvenated appearance thus driving the growth of the blepharoplasty market.

The hospitals segment is expected to have the highest CAGR during the forecast period

The hospitals segment is anticipated to witness the highest CAGR growth during the forecast period, due to the rise in patients having cosmetic surgery performed at hospitals as well as the increase in hospitals offering surgical procedures for the eyelid using cutting-edge medical technology. The postoperative treatment and instructions are given by hospital staff and may include recommendations for managing pain, caring for open wounds, and lowering swelling and bruising. Once a patient is stable and awake, they are typically released detailed postoperative instructions, including information on eye care, drugs, and activities to avoid during the early recovery phase, are frequently given to patients by hospital staff and surgeons.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the presence of pharmaceutical and medical device manufacturers in the area, as well as the increase in the geriatric population in nations like China and India, are both responsible for the market growth in this area. an increase in the number of elderly people, a rise in the number of people who have saggy or droopy upper eyelids as a result of sedentary lifestyles, and an increase in screen time as a result of the COVID-19 epidemic. Additionally, it is anticipated that the market for blepharoplasty would experience rise throughout the projection period because to the growing inclination for minimally invasive procedures. Double eyelid surgery is the most popular procedure in several Asian nations, particularly in Korea enhances the market growth in this region.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, owing to the existence of several significant key players and the rapid technological advancement of medical devices in this area. The main driver of the market's expansion is the rise in the number of people having blepharoplasty treatments to enhance the appearance of their eyes using innovative and sophisticated cosmetic techniques including laser resurfacing and dermal fillers. For instance, a report from the International Society of Aesthetic Plastic Surgery from 2021 estimates that 149,668 eyelid surgery treatments were completed there, compared to 53,253 in the U.S. which are propelling the growth of the regions market.

Key players in the market:

Some of the key players profiled in the Blepharoplasty Market include: Abbvie Inc, Allergan, Alma Lasers, Cynosure, Erchonia Corporation, Galderma, Grand Aespio Inc., Hologic, Johnson & Johnson, LightScalpel, London Bridge Plastic Surgery, Lumenis, M A Corporation, Medline industries, inc., Medtronic plc, Merz Pharma, Sientra, Sisram Medical Ltd, Surgical Holdings Ltd, Valeant Pharmaceuticals International and Zimmer Biomet.

Key Developments:

In October 2023, Allergan Aesthetics and Girls Inc. partner to speed the entry of young Women into Positions of Leadership in the STEM Field. The Allergan Aesthetics effort will focus specifically on leadership paths in STEM (science, technology, engineering, and math).

In October 2023, Johnson & Johnson Company announced a development and commercialization agreement with Sanofi for Janssen's extraintestinal pathogenic Escherichia coli (ExPEC) investigational vaccine program. The lead vaccine candidate is currently being evaluated in the Phase 3 E.mbrace study for the prevention of invasive E. coli disease (IED) in adults aged 60 years and older.

In July 2023, AbbVie and Calibr expand strategic collaboration to advance several preclinical and early-stage clinical assets. This partnership is an expansion of the collaboration AbbVie and Scripps Research formed in 2019 to develop a broad range of potential new and novel therapeutics.

Types Covered:

  • Upper Eyelid Blepharoplasty
  • Lower Eyelid Blepharoplasty
  • Combination Eyelid Surgery

Genders Covered:

  • Female
  • Male

Service Providers Covered:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centre

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Emerging Markets
  • 3.7 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Blepharoplasty Market, By Type

  • 5.1 Introduction
  • 5.2 Upper Eyelid Blepharoplasty
  • 5.3 Lower Eyelid Blepharoplasty
  • 5.4 Combination Eyelid Surgery

6 Global Blepharoplasty Market, By Gender

  • 6.1 Introduction
  • 6.2 Female
  • 6.3 Male

7 Global Blepharoplasty Market, By Service Provider

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Clinics
  • 7.4 Ambulatory Surgical Centre

8 Global Blepharoplasty Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.8 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Abbvie Inc
  • 10.2 Allergan
  • 10.3 Alma Lasers
  • 10.4 Cynosure
  • 10.5 Erchonia Corporation
  • 10.6 Galderma
  • 10.7 Grand Aespio Inc.
  • 10.8 Hologic
  • 10.9 Johnson & Johnson
  • 10.10 LightScalpel
  • 10.11 London Bridge Plastic Surgery
  • 10.12 Lumenis
  • 10.13 M A Corporation
  • 10.14 Medline industries, inc.
  • 10.15 Medtronic plc
  • 10.16 Merz Pharma
  • 10.17 Sientra
  • 10.18 Sisram Medical Ltd
  • 10.19 Surgical Holdings Ltd.
  • 10.20 Valeant Pharmaceuticals International
  • 10.21 Zimmer Biomet

List of Tables

  • Table 1 Global Blepharoplasty Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Blepharoplasty Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Blepharoplasty Market Outlook, By Upper Eyelid Blepharoplasty (2021-2030) ($MN)
  • Table 4 Global Blepharoplasty Market Outlook, By Lower Eyelid Blepharoplasty (2021-2030) ($MN)
  • Table 5 Global Blepharoplasty Market Outlook, By Combination Eyelid Surgery (2021-2030) ($MN)
  • Table 6 Global Blepharoplasty Market Outlook, By Gender (2021-2030) ($MN)
  • Table 7 Global Blepharoplasty Market Outlook, By Female (2021-2030) ($MN)
  • Table 8 Global Blepharoplasty Market Outlook, By Male (2021-2030) ($MN)
  • Table 9 Global Blepharoplasty Market Outlook, By Service Provider (2021-2030) ($MN)
  • Table 10 Global Blepharoplasty Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 11 Global Blepharoplasty Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 12 Global Blepharoplasty Market Outlook, By Ambulatory Surgical Centre (2021-2030) ($MN)
  • Table 13 North America Blepharoplasty Market Outlook, By Country (2021-2030) ($MN)
  • Table 14 North America Blepharoplasty Market Outlook, By Type (2021-2030) ($MN)
  • Table 15 North America Blepharoplasty Market Outlook, By Upper Eyelid Blepharoplasty (2021-2030) ($MN)
  • Table 16 North America Blepharoplasty Market Outlook, By Lower Eyelid Blepharoplasty (2021-2030) ($MN)
  • Table 17 North America Blepharoplasty Market Outlook, By Combination Eyelid Surgery (2021-2030) ($MN)
  • Table 18 North America Blepharoplasty Market Outlook, By Gender (2021-2030) ($MN)
  • Table 19 North America Blepharoplasty Market Outlook, By Female (2021-2030) ($MN)
  • Table 20 North America Blepharoplasty Market Outlook, By Male (2021-2030) ($MN)
  • Table 21 North America Blepharoplasty Market Outlook, By Service Provider (2021-2030) ($MN)
  • Table 22 North America Blepharoplasty Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 23 North America Blepharoplasty Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 24 North America Blepharoplasty Market Outlook, By Ambulatory Surgical Centre (2021-2030) ($MN)
  • Table 25 Europe Blepharoplasty Market Outlook, By Country (2021-2030) ($MN)
  • Table 26 Europe Blepharoplasty Market Outlook, By Type (2021-2030) ($MN)
  • Table 27 Europe Blepharoplasty Market Outlook, By Upper Eyelid Blepharoplasty (2021-2030) ($MN)
  • Table 28 Europe Blepharoplasty Market Outlook, By Lower Eyelid Blepharoplasty (2021-2030) ($MN)
  • Table 29 Europe Blepharoplasty Market Outlook, By Combination Eyelid Surgery (2021-2030) ($MN)
  • Table 30 Europe Blepharoplasty Market Outlook, By Gender (2021-2030) ($MN)
  • Table 31 Europe Blepharoplasty Market Outlook, By Female (2021-2030) ($MN)
  • Table 32 Europe Blepharoplasty Market Outlook, By Male (2021-2030) ($MN)
  • Table 33 Europe Blepharoplasty Market Outlook, By Service Provider (2021-2030) ($MN)
  • Table 34 Europe Blepharoplasty Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 35 Europe Blepharoplasty Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 36 Europe Blepharoplasty Market Outlook, By Ambulatory Surgical Centre (2021-2030) ($MN)
  • Table 37 Asia Pacific Blepharoplasty Market Outlook, By Country (2021-2030) ($MN)
  • Table 38 Asia Pacific Blepharoplasty Market Outlook, By Type (2021-2030) ($MN)
  • Table 39 Asia Pacific Blepharoplasty Market Outlook, By Upper Eyelid Blepharoplasty (2021-2030) ($MN)
  • Table 40 Asia Pacific Blepharoplasty Market Outlook, By Lower Eyelid Blepharoplasty (2021-2030) ($MN)
  • Table 41 Asia Pacific Blepharoplasty Market Outlook, By Combination Eyelid Surgery (2021-2030) ($MN)
  • Table 42 Asia Pacific Blepharoplasty Market Outlook, By Gender (2021-2030) ($MN)
  • Table 43 Asia Pacific Blepharoplasty Market Outlook, By Female (2021-2030) ($MN)
  • Table 44 Asia Pacific Blepharoplasty Market Outlook, By Male (2021-2030) ($MN)
  • Table 45 Asia Pacific Blepharoplasty Market Outlook, By Service Provider (2021-2030) ($MN)
  • Table 46 Asia Pacific Blepharoplasty Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 47 Asia Pacific Blepharoplasty Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 48 Asia Pacific Blepharoplasty Market Outlook, By Ambulatory Surgical Centre (2021-2030) ($MN)
  • Table 49 South America Blepharoplasty Market Outlook, By Country (2021-2030) ($MN)
  • Table 50 South America Blepharoplasty Market Outlook, By Type (2021-2030) ($MN)
  • Table 51 South America Blepharoplasty Market Outlook, By Upper Eyelid Blepharoplasty (2021-2030) ($MN)
  • Table 52 South America Blepharoplasty Market Outlook, By Lower Eyelid Blepharoplasty (2021-2030) ($MN)
  • Table 53 South America Blepharoplasty Market Outlook, By Combination Eyelid Surgery (2021-2030) ($MN)
  • Table 54 South America Blepharoplasty Market Outlook, By Gender (2021-2030) ($MN)
  • Table 55 South America Blepharoplasty Market Outlook, By Female (2021-2030) ($MN)
  • Table 56 South America Blepharoplasty Market Outlook, By Male (2021-2030) ($MN)
  • Table 57 South America Blepharoplasty Market Outlook, By Service Provider (2021-2030) ($MN)
  • Table 58 South America Blepharoplasty Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 59 South America Blepharoplasty Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 60 South America Blepharoplasty Market Outlook, By Ambulatory Surgical Centre (2021-2030) ($MN)
  • Table 61 Middle East & Africa Blepharoplasty Market Outlook, By Country (2021-2030) ($MN)
  • Table 62 Middle East & Africa Blepharoplasty Market Outlook, By Type (2021-2030) ($MN)
  • Table 63 Middle East & Africa Blepharoplasty Market Outlook, By Upper Eyelid Blepharoplasty (2021-2030) ($MN)
  • Table 64 Middle East & Africa Blepharoplasty Market Outlook, By Lower Eyelid Blepharoplasty (2021-2030) ($MN)
  • Table 65 Middle East & Africa Blepharoplasty Market Outlook, By Combination Eyelid Surgery (2021-2030) ($MN)
  • Table 66 Middle East & Africa Blepharoplasty Market Outlook, By Gender (2021-2030) ($MN)
  • Table 67 Middle East & Africa Blepharoplasty Market Outlook, By Female (2021-2030) ($MN)
  • Table 68 Middle East & Africa Blepharoplasty Market Outlook, By Male (2021-2030) ($MN)
  • Table 69 Middle East & Africa Blepharoplasty Market Outlook, By Service Provider (2021-2030) ($MN)
  • Table 70 Middle East & Africa Blepharoplasty Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 71 Middle East & Africa Blepharoplasty Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 72 Middle East & Africa Blepharoplasty Market Outlook, By Ambulatory Surgical Centre (2021-2030) ($MN)